Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and metabolism of radiolabeled BMS-986195 in healthy male subjects
NL-OMON44627Active, not recruiting
- Sponsor
- Bristol Myers Squibb
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of branebrutinib in rheumatoid arthritis (RA), sponsored by Bristol Myers Squibb. Primary endpoint: Pharmacokinetics, metabolism routes, and extent of elimination. Started Aug 2017; status: active, not recruiting.
02
Drugs
branebrutinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON44627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44627.